Saturday, October 31, 2026

Peru: American Leaders United Against Corruption at 8th Summit of the Americas

Cecilia Demartini

April 16, 2018

8th Summit of the Americas.
MONTEVIDEO, Uruguay (ViaNews) - Held every three years since its first edition in 1994, the Eight Summit of the Americas came to an end last Saturday in Lima, Perú. During two days the heads of state and government representatives of the Western Hemisphere gathered on the Summit´s main topic “Democratic Governance against Corruption”. The United States President Donald Trump canceled what would have been his first visit to Latin America. The North American country was represented at the VIII Summit of the Americas by its vice-president Mike Pence. El Salvador, Guatemala, and Paraguay also sent their respective representatives. During the inauguration of the Summit in Perú last week the President of Peru Martín Vizcarra stated: “I call on you to work together in order to consolidate a democratic and peaceful society in the hemisphere, that supports human dignity and fosters the development of our peoples.” “Overcoming corruption will bring us stability and new opportunities.” “It’s an urgent need to act jointly in the face of a common challenge and meet our peoples’ expectations,” Vizcarra added. Vizcarra replaced former President of Peru, Pedro Pablo Kuczynski who resigned by the end of March in the middle of a corruption scandal, linking him with the Brazilian construction company Odebrecht. Among the presidents and heads of state attending the Summit were Canada Prime Minister, Justin Trudeau, the President of Brazil, Michel Temer, the President of Argentina, Mauricio Macri, and President of Uruguay, Tabaré Vázquez. Dignitaries participating also held private dialogues such is the case of the President of Uruguay who met with the President of Brazil, Michel Temer and the President of Argentina, Mauricio Macri to discuss themes related to regional security and the Mercosur. The Secretary-General of the Organization of American States (OAS) Luis Almagro was also present at the Summit. “It´s an honor to participate in the inauguration of the Summit of the Americas. The region is facing problems that go far beyond the strategic: freeing our hemispheric community from corruption is an existential task,“ stated Almagro. The OAS and Mexico signed an agreement, during the Summit, for the deployment of a Mission to observe the July 1 federal and local elections with the former President of the Dominican Republic, Leonel Fernández, as Chief of Mission. In July Mexicans will elect the president, 128 senators, 500 deputies, 8 governors, Mexico City Mayor and thousands of local and municipal posts. Secretary-General, Luis Almagro designated former President of the Dominican Republic Leonel Fernández as Chief of Mission.

On Venezuela

By the end of the Summit, a declaration was issued and signed by the United States and 16 countries demanding "presidential elections with the guarantees required for a free, fair, transparent and democratic process, without political prisoners, including the participation of all Venezuelan political actors. The elections that do not comply with these conditions will lack legitimacy and credibility. " As the Summit came to an end, the President of Peru, Martín Vizcarra stated: “As president of this Eight Summit, I express my gratitude to the countries that participated with the firm objective of adopting specific commitments and measures to face corruption.”

In this story · Knowledge Files

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Data Wave Builds Toward Ivonescimab PDUFA, While Micro-Cap Biotech Exits the Market
Late October 2026 is a dense catalyst window led by ESMO 2026. Daiichi Sankyo's DXd antibody-drug conjugate (ADC) programs (DESTINY-Lung04, DESTINY-Breast11, REJOICE-Ovarian01/02, TUXEDO-3), Guardant's 25 abstracts and the PACE-LUNG ctDNA trial all report there. These feed into the FDA's 14 November 2026 PDUFA date for ivonescimab. Large and mid-cap developers with late-stage data and commercial launches (ZEGFROVY, ANKTIVA, MIUDELLA, lorundrostat, duvakitug) are drawing capital and attention. Spago Nanomedical's board decision to seek a Nasdaq First North delisting (EGM 19 November, application 25 January 2027) shows the capital squeeze on early-stage, single-asset names (Tumorad is Phase I).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,514 source documents archived
Query this data → isubstrate.com